Efficacy of dabrafenib-trametinib combination in BRAF V600E-mutated metastatic non–small cell lung cancer: Results of the IFCT-2004 BLaDE cohort.
- Etude concernée: IFCT-2004
- Journal / Conference: ASCO
- Année / Year: 2022
- PMID: Poster session
- Lien vers la publication: https://meetings.asco.org/abstracts-presentations/208898